In the recent past there has been little innovation in the traditional pharmaceutical industry with hardly any breakthroughs. Many diseases still remains untreated and prevented. However Vaccines and biopharmaceuticals are now achieving the fastest growth rate typically because the Physicians are able to prevent and treat diseases which traditional pharma has not been able to prevent OR treat. However, one of the greatest challenges associated with Novel Vaccines and Biopharmaceuticals is the cost which stills puts them beyond the reach of a common man in the developing world.
At THPL our endeavor to positively impact and bridge up this gap to the extent possible by enabling creation of a synergistic framework of organizations for maximum output.